A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma

NCT05621668 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma
Bone Sarcoma

Interventions

DRUG: Cyclophosphamide
DRUG: attIL2-T cells

Sponsor

M.D. Anderson Cancer Center